CDISC Therapeutic Area Standard User Guide Highlights
The Coalition For Accelerating Standards and Therapies (CFAST), a joint initiative of CDISC and the Critical Path Institute (C‐Path), was launched to accelerate clinical research and medical product development by facilitating the establishment and maintenance of data standards, tools and methods for conducting research in therapeutic areas (TA) important to public health (cf CDISC webpage). The CFAST Program Steering Committee has released a prioritized list of TA data standards projects. As of today final versions have been released for Alzheimer, Asthma, Multiple Sclerosis, Polycystic Kidney Disease, Parkinson, Virology, Pain, Tuberculosis, while draft for other TA are available for public review such as Cardiovascular Disease. The aim of this poster is to introduce the CDISC‐TA UG project and new concepts introduced.
Empfohlen
Weitere ähnliche Inhalte
Mehr von Angelo Tinazzi
Mehr von Angelo Tinazzi (20)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
CDISC Therapeutic Area Standard User Guide Highlights
- 1. Da: Angelo Tinazzi Angelo.Tinazzi@cytel.com Oggetto: PhUSE SDE Poster Data: 03 luglio 2014 22:20 A: joseph.rowley@novartis.com, karma.tarap@novartis.com Hi Joseph, Hi Karma, First of all congratulations for the event I have been extremely impressed the way you organized it and most of the presentation were definitively outstanding. In case you are going to publish presentations and posters on the PhUSE website, you can find attached the last version of my poster. Kind Regards Angelo Angelo Tinazzi Associate Director – Statistical Programming Clinical Research Services Cytel, Inc. Shaping the Future of Drug Development Route de Pré-Bois 20 - C.P. 1839 1215 Geneva 15, Switzerland Cell : +41 79 535 99 49 angelo.tinazzi@cytel.com http://www.cytel.com | Blog: http://cytel.hs-sites.com/blog software | consulting | outsourcing | biostatistics & data management __________________________ This e-mail (including any attachments) is confidential and may be legally privileged. If you are not an intended recipient or an authorized representative of an intended recipient, you are prohibited from using, copying or distributing the information in this e-mail or its attachments. If you have received this e-mail in error, please notify the sender immediately by return e-mail and delete all copies of this message and any attachments. Thank you.